
|Articles|August 1, 2002
Derm drugs pose serious fetal risks
New York - A number of drugs used commonly in dermatology have teratogenic potential, making careful screening and comprehensive and ongoing pregnancy prevention counseling a must when prescribing medications for female patients, Robyn Gmyrek, M.D., said.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Nearly Half of Female Psoriasis Patients Report IPV, Study Finds
3
The Weekly Roundup: December 1-5
4
Experts See Promise in AI for Atopic Dermatitis Care
5


















